| epirubicin / Generic mfg. |
NCT00869284: Long-Term Follow-up of Tandem High-Dose Therapy With Peripheral Blood Stem Cell for Adults With High-Risk Age-Adjusted IPI Aggressive Non-Hodgkin's Lymphomas |
|
|
| Completed | 2 | 45 | Europe | CEEP regimen, Tandem high-dose therapy (HDT) followed by autologous peripheral blood stem cell (PBSC) | French Innovative Leukemia Organisation, Amgen | Lymphoma | 07/99 | 02/09 | | |
NCT00262210: A Comparative Study for Non-Hodgkin's Lymphoma in Hepatitis B Virus Carriers |
|
|
| Completed | 2 | 50 | RoW | Cyclophosphamide Epirubicin Etoposide Prednisolone | National Health Research Institutes, Taiwan | Non-Hodgkin's Lymphoma | | 12/99 | | |
NCT00062296: Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia |
|
|
| Completed | 2 | 5 | US | rituximab, epirubicin hydrochloride | Fox Chase Cancer Center, National Cancer Institute (NCI) | Leukemia, Lymphoma | 08/05 | 08/05 | | |
NCT00556127: Rituximab in Addition to Chemotherapy With Autologous Stem Cell Transplantation as Treatment Diffuse Large B-Cell Lymphoma |
|
|
| Completed | 2 | 94 | Europe | Rituximab, Epirubicin, Cyclophosphamide, Vincristine, Prednisone, Granulocyte-colony-stimulating factor, Mitoxantrone, Cytarabine ARA-C, Dexamethasone, Carmustine BCNU, Etoposide, Melphalan, Radiotherapy, PBSC reinfusion | Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie | Diffuse Large B-Cell Lymphoma, POOR PROGNOSIS | | 09/06 | | |
| Unknown status | 2 | 60 | Europe | carmustine, cyclophosphamide, cytarabine, doxorubicin hydrochloride, epirubicin hydrochloride, etoposide, ifosfamide, melphalan, methotrexate, prednisolone, vincristine sulfate, autologous hematopoietic stem cell transplantation, biopsy, peripheral blood stem cell transplantation | Cancer Research UK | Lymphoma, Small Intestine Cancer | | | | |
NCT00003262: Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection |
|
|
| Unknown status | 2 | 30 | Europe | bleomycin sulfate, filgrastim, Stanford V regimen, doxorubicin hydrochloride, epirubicin hydrochloride, etoposide, mechlorethamine hydrochloride, prednisone, vinblastine sulfate, vincristine sulfate | Centro di Riferimento Oncologico - Aviano | Lymphoma | | | | |
NCT04899570: Zanubrutinib Combined With R-CHOP in Newly-diagnosed Intravascular Large B-cell Lymphoma |
|
|
| Recruiting | 2 | 20 | RoW | Zanubrutinib, BRUKINSA, Rituximab, Rituxan, Cyclophosphamide, Epirubicin, Vindesine, Prednisone | Peking Union Medical College Hospital | Intravascular Large B-Cell Lymphoma | 04/23 | 04/25 | | |
NCT04214626: R-CHOP Combined With Lenalidomide in the First-line Treatment for Patients With Diffuse Large B Cell Lymphoma |
|
|
| Active, not recruiting | 2 | 60 | RoW | Rituximab, RiTUXimab Injection, Lenalidomide, Lenalidomide capsule, Cyclophosphamide, Cyclophosphamide Injection, Epirubicin, Epirubicin hydrochloride, Vincristine, Vincristine Injection, Prednisone, Prednisone Oral Product, Methotrexate, Methotrexate Injectable Solution | Henan Cancer Hospital | Diffuse Large B Cell Lymphoma | 11/23 | 01/25 | | |
| Recruiting | 2 | 52 | RoW | Azacitidine in combination with R-CHOP | The First Affiliated Hospital of Xiamen University, Jiangsu Provincial People's Hospital, Sun Yat-sen University, Chinese Academy of Medical Sciences, Shanxi Province Cancer Hospital | DLBCL - Diffuse Large B Cell Lymphoma, TP53 | 05/25 | 05/25 | | |
NCT04067037: Camrelizumab Combined With AVD in the First-line Treatment for Patients With Advanced Classical Hodgkin's Lymphoma |
|
|
| Recruiting | 2 | 60 | RoW | Camrelizumab, SHR-1210, Epirubicin, Epirubicin hydrochloride, Vincristine, Oncovin, Dacarbazine | Henan Cancer Hospital | Classical Hodgkin Lymphoma | 06/24 | 12/24 | | |
NCT04433156: VR-CAP in the First-line Treatment for Patients With Marginal Zone Lymphoma |
|
|
| Recruiting | 2 | 60 | RoW | Bortezomib, Bortezomib Injection, Rituximab, RiTUXimab Injection, Epirubicin, Epirubicin hydrochloride, Cyclophosphamide, Cyclophosphamide Injection, Prednisone, Prednisone Oral Product | Henan Cancer Hospital | Marginal Zone Lymphoma | 12/23 | 04/25 | | |
NCT04668365: Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma |
|
|
| Recruiting | 2 | 59 | RoW | Rituximab, RiTUXimab Injection, Zanubrutinib, Zanubrutinib Pill, Cyclophosphamide, Cyclophosphamide Injection, Epirubicin, Epirubicin Injection, Vincristine, Vincristine Injection, Prednisone, Prednisone Pill | Henan Cancer Hospital | Diffuse Large B Cell Lymphoma, CD79A Gene Mutation, CD79B Gene Mutation | 12/23 | 12/25 | | |
NCT05290090: ZR2 Followed by Immunochemotherapy in Elderly Patients With Newly-diagnosed DLBCL |
|
|
| Recruiting | 2 | 31 | RoW | Rituximab, Lenalidomide, Zanubrutinib and RCHOP, BGB-3111 | Zhejiang Cancer Hospital | Diffuse Large B Cell Lymphoma | 06/24 | 12/25 | | |
NCT05887726: Zanubrutinib Combined With R-CHOP Regimen in the Treatment of Newly Diagnosed DLBCL With High-risk Factors |
|
|
| Not yet recruiting | 2 | 30 | RoW | Zanubrutinib, Rituximab, Cyclophosphamide, Epirubicin, Vincristine, Prednisone | Liaoning Tumor Hospital & Institute | Diffuse Large B Cell Lymphoma | 08/24 | 08/25 | | |
NCT05572983: Phase Ⅱ Study of Chidamide in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype |
|
|
| Recruiting | 2 | 47 | RoW | Chidamide combined with CHOP, Induction treatment, Chidamide, Maintenance treatment | Sun Yat-sen University | Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype | 09/24 | 09/26 | | |
NCT05933967: A Study of Orelabrutinib Plus R-CHOP in Treatment-naïve Patients With Double Expression Diffuse Large B-cell Lymphoma |
|
|
| Recruiting | 2 | 31 | RoW | Orelabrutinib+R-CHOP | Shandong Cancer Hospital and Institute, The First Affiliated Hospital of Nanchang University | The First Affiliated Hospital of Nanchang University | 12/24 | 12/26 | | |
NCT02987244: Chidamide Plus CHOEP Combined With Upfront ASCT in Untreated Peripheral T-cell Lymphoma |
|
|
| Recruiting | 1/2 | 100 | RoW | Chidamide, epidaza, Cyclophosphamide, Epirubicin, Vindesine, Etoposide, Prednisone | Peking Union Medical College Hospital, Chinese PLA General Hospital, Peking University First Hospital, Peking University Third Hospital, Peking University Cancer Hospital & Institute, Tianjin Medical University Cancer Institute and Hospital | T Cell Non-Hodgkin's Lymphoma | 03/20 | 03/23 | | |
NCT06421948: Linperlisib Combined With Chidamide in Patients With PTCL |
|
|
| Recruiting | 1/2 | 100 | RoW | Linperlisib and chidamide, cyclophosphamide, doxorubicin/epirubicin, vincristine, and prednisone | Yanyan Liu | Peripheral T-cell Lymphoma | 12/25 | 05/26 | | |
